Phase I trial of immunological adjuvant SAFm in melanoma patients vaccinated with antiidiotype antibody MELIMMUNE-1

Authors
Category Primary study
JournalVaccine Research
Year 1994
This article has no abstract
Epistemonikos ID: 6fd852b3221dc63cb2ed090ba8b6f38b763d3ce1
First added on: Feb 03, 2025